Page 4 - Pfizer Global Product Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer Unveils Oncology Advances at ASCO 2023 Meeting

Pfizer Unveils Oncology Advances at ASCO 2023 Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaDany habrChris boshoffPierre fabreEuropean medicines agencyPfizer global product developmentDrug administrationPfizer incOno pharmaceutical co ltdAmerican society of clinical oncologyClinical oncologyAnnual meetingChief development officerRare diseasePfizer global product

FDA Accepts Supplemental New Drug Application for Encorafenib, Binimetinib Combination in NSCLC

The application is based on the PHAROS trial, which met its primary endpoint of objective response rate in patients with metastatic non–small cell lung cancer with a BRAF V600E mutation.

United statesChris boshoffAmerican cancer societyPfizer global product developmentNew drug applicationPrescription drug user fee act

FDA to Review Drug Duo for BRAF-Mutant Lung Cancer

The Food and Drug Administration will review Braftovi plus Mektovi for the treatment of patients with metastatic BRAF V600E-mutant non-small cell lung cancer.

Braftovi mektoviChris boshoffPfizer global product developmentNational cancer instituteDrug administrationSupplemental new drug applicationLung cancer

FDA Accepts Pfizer s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI

FDA Accepts Pfizer s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaPierre fabreChris boshoffPfizer global product developmentOno pharmaceutical coExchange commissionWorld health organizationAmerican cancer societyInternational agency for research on cancerAmerican lung associationPfizer incDrug administrationSupplemental new drug applicationsPrescription drug user fee actPfizer oncology

FDA OKs Pfizer s Supplemental New Drug Apps for BRAFTOVI + MEKTOVI

FDA OKs Pfizer s Supplemental New Drug Apps for BRAFTOVI + MEKTOVI
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesChris boshoffPierre fabreOno pharmaceutical coDrug administrationAmerican cancer societyPfizer global product developmentPfizer incSupplemental new drug applicationsPrescription drug user fee actPfizer oncologyChief development officerRare diseasePfizer global productNon small cell lung cancer